Literature DB >> 12645943

Costimulation of human CD28- T cells by 4-1BB ligand.

Jacob Bukczynski1, Tao Wen, Tania H Watts.   

Abstract

The T cell surface protein CD28 provides a critical costimulatory signal for T cell activation. With age, humans accumulate increasing numbers of CD28- T cells, and this loss of CD28 expression is exacerbated certain disease states, such as HIV infection, autoimmune conditions or cancer. It is unclear whether CD28- T cells represent terminally differentiated effector cells or whether they remain sensitive to costimulation by CD28-independent pathways. Here, we demonstrate that 4-1 BB ligand can costimulate human CD28- T cells, resulting in cell division, inflammatory cytokine production, increased perforin levels, enhancement of cytolytic effector function, as well as the up-regulation of the anti-apoptotic protein Bcl-X(L). Thus, human CD28- T cells can respond to costimulatory signals and as such become attractive targets for therapeutic intervention, particularly in chronic infectious and inflammatory diseases where large numbers of these cells accumulate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12645943     DOI: 10.1002/immu.200310020

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

Review 1.  Approaches to studying costimulation of human antiviral T cell responses: prospects for immunotherapeutic vaccines.

Authors:  Lena Serghides; Mariana Vidric; Tania H Watts
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 2.  T-cell activation in the intestinal mucosa.

Authors:  Dina Montufar-Solis; Tomas Garza; John R Klein
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

3.  4-1BB ligand enhances tumor-specific immunity of poxvirus vaccines.

Authors:  Chie Kudo-Saito; James W Hodge; Heesun Kwak; Seunghee Kim-Schulze; Jeffrey Schlom; Howard L Kaufman
Journal:  Vaccine       Date:  2006-03-31       Impact factor: 3.641

4.  T cell costimulatory molecules in anti-viral immunity: Potential role in immunotherapeutic vaccines.

Authors:  Tania H Watts; Edward M Bertram; Jacob Bukczynski; Tao Wen
Journal:  Can J Infect Dis       Date:  2003-07

Review 5.  KLRG1--more than a marker for T cell senescence.

Authors:  Sian M Henson; Arne N Akbar
Journal:  Age (Dordr)       Date:  2009-12

Review 6.  The TNF family in T cell differentiation and function--unanswered questions and future directions.

Authors:  Michael Croft
Journal:  Semin Immunol       Date:  2014-03-06       Impact factor: 11.130

7.  HIV-specific CD8+ T cells from elite controllers are primed for survival.

Authors:  Jiyu Yan; Steffanie Sabbaj; Anju Bansal; Nilesh Amatya; John J Shacka; Paul A Goepfert; Sonya L Heath
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

8.  4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease.

Authors:  Douglas G Mack; Allison K Lanham; Brent E Palmer; Lisa A Maier; Tania H Watts; Andrew P Fontenot
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

9.  Decreased 4-1BB expression on HIV-specific CD4+ T cells is associated with sustained viral replication and reduced IL-2 production.

Authors:  Afework Kassu; Michelle D'Souza; Brian P O'Connor; Elizabeth Kelly-McKnight; Ramesh Akkina; Andrew P Fontenot; Brent E Palmer
Journal:  Clin Immunol       Date:  2009-04-29       Impact factor: 3.969

10.  Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.

Authors:  Jing-Hua Huang; Song-Nan Zhang; Kyung-Ju Choi; Il-Kyu Choi; Joo-Hang Kim; Min-Geol Lee; Mingul Lee; Hoguen Kim; Chae-Ok Yun
Journal:  Mol Ther       Date:  2009-09-08       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.